SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001176256-14-000170
Filing Date
2014-04-21
Accepted
2014-04-21 17:28:25
Documents
5
Period of Report
2014-06-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE MONTH OF APRIL 2014 nymox6kampm140421.htm 6-K/A 5456
2 LETTER TO THE SECURITIES AND EXCHANGE COMMISSION exhibit99-1.htm EX-99.1 1819
3 NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR exhibit99-2.htm EX-99.2 137368
4 exhibit99-1x1x1.jpg GRAPHIC 3136
5 exhibit99-2x7x1.jpg GRAPHIC 58733
  Complete submission text file 0001176256-14-000170.txt   231199
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-12033 | Film No.: 14774607
SIC: 2835 In Vitro & In Vivo Diagnostic Substances